参天製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/05/19 | 997 | 1,011 | 997 | 1,009 | -10 | -1% | 3,363,400 |
| 2022/05/18 | 1,014 | 1,027 | 1,006 | 1,019 | +6 | +0.6% | 3,247,800 |
| 2022/05/17 | 1,005 | 1,029 | 1,005 | 1,013 | +13 | +1.3% | 3,522,300 |
| 2022/05/16 | 1,036 | 1,039 | 995 | 1,000 | -29 | -2.8% | 3,969,200 |
| 2022/05/13 | 1,010 | 1,033 | 990 | 1,029 | +8 | +0.8% | 5,648,800 |
| 2022/05/12 | 1,060 | 1,062 | 1,020 | 1,021 | -43 | -4% | 3,937,400 |
| 2022/05/11 | 1,093 | 1,105 | 1,050 | 1,064 | -30 | -2.7% | 4,057,400 |
| 2022/05/10 | 1,073 | 1,101 | 1,070 | 1,094 | +19 | +1.8% | 3,787,600 |
| 2022/05/09 | 1,076 | 1,084 | 1,063 | 1,075 | -20 | -1.8% | 3,512,000 |
| 2022/05/06 | 1,088 | 1,098 | 1,064 | 1,095 | +16 | +1.5% | 2,867,900 |
| 2022/05/02 | 1,061 | 1,082 | 1,056 | 1,079 | +16 | +1.5% | 1,690,000 |
| 2022/04/28 | 1,040 | 1,063 | 1,039 | 1,063 | +29 | +2.8% | 1,808,300 |
| 2022/04/27 | 1,026 | 1,037 | 1,017 | 1,034 | -5 | -0.5% | 2,435,300 |
| 2022/04/26 | 1,039 | 1,053 | 1,033 | 1,039 | ±0 | ±0% | 1,831,900 |
| 2022/04/25 | 1,032 | 1,044 | 1,024 | 1,039 | -13 | -1.2% | 2,157,200 |
| 2022/04/22 | 1,048 | 1,054 | 1,035 | 1,052 | +6 | +0.6% | 2,638,900 |
| 2022/04/21 | 1,022 | 1,054 | 1,021 | 1,046 | +26 | +2.5% | 2,772,400 |
| 2022/04/20 | 1,018 | 1,037 | 1,008 | 1,020 | +11 | +1.1% | 2,881,600 |
| 2022/04/19 | 1,017 | 1,032 | 1,006 | 1,009 | -4 | -0.4% | 3,789,900 |
| 2022/04/18 | 1,039 | 1,047 | 1,007 | 1,013 | -32 | -3.1% | 3,545,600 |
| 2022/04/15 | 1,072 | 1,075 | 1,043 | 1,045 | -37 | -3.4% | 4,000,300 |
| 2022/04/14 | 1,104 | 1,127 | 1,081 | 1,082 | -17 | -1.5% | 3,230,500 |
| 2022/04/13 | 1,097 | 1,122 | 1,090 | 1,099 | +10 | +0.9% | 3,856,800 |
| 2022/04/12 | 1,147 | 1,150 | 1,081 | 1,089 | -121 | -10% | 4,482,900 |
| 2022/04/11 | 1,209 | 1,220 | 1,204 | 1,210 | -5 | -0.4% | 1,410,600 |
| 2022/04/08 | 1,226 | 1,228 | 1,207 | 1,215 | +3 | +0.2% | 1,577,900 |
| 2022/04/07 | 1,200 | 1,212 | 1,191 | 1,212 | +6 | +0.5% | 1,864,300 |
| 2022/04/06 | 1,224 | 1,230 | 1,204 | 1,206 | -19 | -1.6% | 2,010,000 |
| 2022/04/05 | 1,250 | 1,251 | 1,218 | 1,225 | -13 | -1.1% | 1,796,400 |
| 2022/04/04 | 1,230 | 1,241 | 1,221 | 1,238 | +10 | +0.8% | 1,266,900 |
| 2022/04/01 | 1,220 | 1,235 | 1,209 | 1,228 | +1 | +0.1% | 1,388,700 |
| 2022/03/31 | 1,257 | 1,267 | 1,227 | 1,227 | -42 | -3.3% | 2,312,200 |
| 2022/03/30 | 1,305 | 1,308 | 1,259 | 1,269 | -33 | -2.5% | 1,513,900 |
| 2022/03/29 | 1,300 | 1,309 | 1,291 | 1,302 | -2 | -0.2% | 1,344,700 |
| 2022/03/28 | 1,321 | 1,321 | 1,301 | 1,304 | -29 | -2.2% | 695,900 |
| 2022/03/25 | 1,324 | 1,339 | 1,321 | 1,333 | +15 | +1.1% | 745,700 |
| 2022/03/24 | 1,339 | 1,339 | 1,311 | 1,318 | -17 | -1.3% | 842,800 |
| 2022/03/23 | 1,319 | 1,338 | 1,310 | 1,335 | +40 | +3.1% | 984,400 |
| 2022/03/22 | 1,315 | 1,324 | 1,290 | 1,295 | -28 | -2.1% | 1,531,700 |
| 2022/03/18 | 1,322 | 1,328 | 1,307 | 1,323 | +13 | +1% | 1,838,100 |
| 2022/03/17 | 1,341 | 1,341 | 1,309 | 1,310 | -3 | -0.2% | 1,651,300 |
| 2022/03/16 | 1,309 | 1,326 | 1,309 | 1,313 | +28 | +2.2% | 1,782,900 |
| 2022/03/15 | 1,246 | 1,290 | 1,246 | 1,285 | +39 | +3.1% | 1,164,300 |
| 2022/03/14 | 1,260 | 1,270 | 1,245 | 1,246 | -3 | -0.2% | 727,800 |
| 2022/03/11 | 1,271 | 1,273 | 1,243 | 1,249 | -19 | -1.5% | 1,609,300 |
| 2022/03/10 | 1,261 | 1,274 | 1,249 | 1,268 | +44 | +3.6% | 1,260,500 |
| 2022/03/09 | 1,217 | 1,234 | 1,210 | 1,224 | -12 | -1% | 1,036,800 |
| 2022/03/08 | 1,222 | 1,253 | 1,222 | 1,236 | +5 | +0.4% | 1,513,300 |
| 2022/03/07 | 1,235 | 1,238 | 1,215 | 1,231 | -15 | -1.2% | 1,403,800 |
| 2022/03/04 | 1,255 | 1,261 | 1,240 | 1,246 | -22 | -1.7% | 1,330,800 |
801～
850
件表示中 / 3767件
類似銘柄と比較する
現在ご覧いただいている「参天薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 参天薬 | 157,500円 | -2.0% | -7.3% | 2.41% | 15.39倍 | 1.83倍 |
|
緑内障、加齢黄斑変性、ドライアイ治療薬など眼科用医薬品首位。一般用目薬「サンテ」が有名 |
| ロート | 253,900円 | +8.4% | +6.4% | 1.65% | 18.22倍 | 2.21倍 |
|
一般用医薬品の目薬で世界首位。「肌研」が急成長しスキンケアが柱に。アジアなど海外積極進出 |
| 住友ファーマ | 144,000円 | -11.0% | +206.6% | 0.00% | 14.30倍 | 3.38倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
| 久光薬 | 429,900円 | +5.8% | +1.2% | 2.79% | 13.92倍 | 1.10倍 |
|
貼る鎮痛消炎剤首位。医療用シェア５割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
| ツムラ | 364,900円 | +3.8% | -19.9% | 3.73% | 11.86倍 | 0.91倍 |
|
医療用漢方薬で国内シェア８割超。高齢者、がん支持療法、女性関連の３領域を重点に市場深耕 |
市場注目の銘柄
チャート関連のコラム
